MedPath

Efficacy of pre operative Tegafur/Uracil and Degarelix combination therapy for high risk prostate cancer

Not Applicable
Conditions
prostate cancer
Registration Number
JPRN-UMIN000036159
Lead Sponsor
Gifu University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patient who is difficult to obtain his consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
survival rate after radical prostatectomy
Secondary Outcome Measures
NameTimeMethod
Adverse event
© Copyright 2025. All Rights Reserved by MedPath